Literature DB >> 27460151

Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease.

Ian M McDonough1, Gérard N Bischof2, Kristen M Kennedy3, Karen M Rodrigue3, Michelle E Farrell3, Denise C Park3.   

Abstract

Measures of core cognitive processes (fluid abilities) are highly correlated with measures of knowledge (crystallized abilities) in healthy adults. In early stages of Alzheimer's disease (AD), fluid abilities, however, decline more rapidly than crystallized abilities. We hypothesized that cognitively normal older adults who evidenced lower fluid ability compared with crystallized ability (an ability discrepancy) would show evidence of early AD neuropathology indexed via in vivo measures of amyloid-beta (Aβ) deposition and cortical thickness in AD-vulnerable regions. A sample of older adults (n = 112) aged 65 to 89 underwent a cognitive battery, structural magnetic resonance imaging, and a subset (n = 75) also completed positron emission tomography scanning to measure Aβ deposition using F-18 Florbetapir. Of this sample, 60 older adults (43 with available positron emission tomography scans) evidenced a discrepancy where fluid ability was lower than crystallized ability. The magnitude of the ability discrepancy was independently associated with a greater Aβ deposition and thinner cortex in AD-vulnerable regions, as well as age. The data suggest that such a discrepancy may be a marker of preclinical AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ability discrepancy; Aging; Amyloid-beta; Cortical thickness; Dementia; Preclinical

Mesh:

Substances:

Year:  2016        PMID: 27460151      PMCID: PMC5018443          DOI: 10.1016/j.neurobiolaging.2016.06.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  47 in total

Review 1.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

2.  Estimation of premorbid intelligence in dementia.

Authors:  R E O'Carroll; C J Gilleard
Journal:  Br J Clin Psychol       Date:  1986-05

3.  Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.

Authors:  S M Resnick; J Sojkova; Y Zhou; Y An; W Ye; D P Holt; R F Dannals; C A Mathis; W E Klunk; L Ferrucci; M A Kraut; D F Wong
Journal:  Neurology       Date:  2010-02-10       Impact factor: 9.910

4.  Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study.

Authors:  Valtteri Julkunen; Eini Niskanen; Juha Koikkalainen; Sanna-Kaisa Herukka; Maija Pihlajamäki; Merja Hallikainen; Miia Kivipelto; Sebastian Muehlboeck; Alan C Evans; Ritva Vanninen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  When does cognitive functioning peak? The asynchronous rise and fall of different cognitive abilities across the life span.

Authors:  Joshua K Hartshorne; Laura T Germine
Journal:  Psychol Sci       Date:  2015-03-13

6.  Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.

Authors:  Miranka Wirth; Cindee M Madison; Gil D Rabinovici; Hwamee Oh; Susan M Landau; William J Jagust
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

7.  Neuropsychological investigation of memory, visuoconstructional, visuoperceptual, and language abilities in senile dementia of the Alzheimer type.

Authors:  W G Rosen
Journal:  Adv Neurol       Date:  1983

8.  The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.

Authors:  Miranka Wirth; Hwamee Oh; Elizabeth C Mormino; Candace Markley; Susan M Landau; William J Jagust
Journal:  Alzheimers Dement       Date:  2013-03-07       Impact factor: 21.566

9.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

10.  Latent change models of adult cognition: are changes in processing speed and working memory associated with changes in episodic memory?

Authors:  Christopher Hertzog; Roger A Dixon; David F Hultsch; Stuart W S MacDonald
Journal:  Psychol Aging       Date:  2003-12
View more
  11 in total

1.  Refining the metamemory in adulthood questionnaire: a 20-item version of change and capacity designed for research and clinical settings.

Authors:  Ian M McDonough; Graham J McDougall; Michael LaRocca; Safiya G Dalmida; Kristopher L Arheart
Journal:  Aging Ment Health       Date:  2019-04-07       Impact factor: 3.658

2.  Functional Connectivity Dynamics Altered of the Resting Brain in Subjective Cognitive Decline.

Authors:  Yi-Chia Wei; Yi-Chia Kung; Wen-Yi Huang; Chemin Lin; Yao-Liang Chen; Chih-Ken Chen; Yu-Chiau Shyu; Ching-Po Lin
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

3.  Linear and nonlinear relationships between cognitive subdomains of ability discrepancy and Alzheimer's disease biomarkers.

Authors:  Ian M McDonough; Taylor E Popp
Journal:  Neuropsychology       Date:  2019-12-02       Impact factor: 3.295

4.  Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer's Disease Research Sample.

Authors:  Yue Ma; Cynthia M Carlsson; Michelle L Wahoske; Hanna M Blazel; Richard J Chappell; Sterling C Johnson; Sanjay Asthana; Carey E Gleason
Journal:  J Int Neuropsychol Soc       Date:  2020-10-05       Impact factor: 2.892

5.  Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field?

Authors:  Ian M McDonough; Shameka L Cody; Erin R Harrell; Stephanie L Garrett; Taylor E Popp
Journal:  Mem Cognit       Date:  2022-03-25

Review 6.  A Review on the Trajectory of Attentional Mechanisms in Aging and the Alzheimer's Disease Continuum through the Attention Network Test.

Authors:  Ian M McDonough; Meagan M Wood; William S Miller
Journal:  Yale J Biol Med       Date:  2019-03-25

Review 7.  Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Authors:  Ruth Peters; John Breitner; Sarah James; Gregory A Jicha; Pierre-Francois Meyer; Marcus Richards; A David Smith; Hussein N Yassine; Erin Abner; Atticus H Hainsworth; Patrick G Kehoe; Nigel Beckett; Christopher Weber; Craig Anderson; Kaarin J Anstey; Hiroko H Dodge
Journal:  Alzheimers Dement (N Y)       Date:  2021-12-08

8.  Beta-amyloid and Cortical Thickness Reveal Racial Disparities in Preclinical Alzheimer's Disease.

Authors:  Ian M McDonough
Journal:  Neuroimage Clin       Date:  2017-09-21       Impact factor: 4.881

9.  Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non-demented older adults.

Authors:  Beth E Snitz; Dana L Tudorascu; Zheming Yu; Elizabeth Campbell; Brian J Lopresti; Charles M Laymon; Davneet S Minhas; Neelesh K Nadkarni; Howard J Aizenstein; William E Klunk; Sandra Weintraub; Richard C Gershon; Ann D Cohen
Journal:  Alzheimers Dement (Amst)       Date:  2020-05-15

10.  Prefrontal Cortical Connectivity Mediates Locus Coeruleus Noradrenergic Regulation of Inhibitory Control in Older Adults.

Authors:  Alessandro Tomassini; Frank H Hezemans; Rong Ye; Kamen A Tsvetanov; Noham Wolpe; James B Rowe
Journal:  J Neurosci       Date:  2022-03-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.